Bill Gates has invested $10 million in computational drug design company Schrödinger, Derek Lowe reports in a Nature News column.
Bill Gates has invested $10 million in computational drug design company Schrödinger, Derek Lowe reports in a Nature News column.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.